CYTOKINETICS, INCORPORATED Interest and Other Income
CYTOKINETICS, INCORPORATED (CYTK) reported Interest and Other Income of $156.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-03.
Discontinued › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2016-03-03
- CYTOKINETICS, INCORPORATED interest and other income for the quarter ending 2013-12-31 was $101.00K, a 206.06% increase year-over-year.
- CYTOKINETICS, INCORPORATED interest and other income for the quarter ending 2013-09-30 was $24.00K, a 20.00% decline year-over-year.
- CYTOKINETICS, INCORPORATED interest and other income for the quarter ending 2013-06-30 was $23.00K, a 76.92% increase year-over-year.
- CYTOKINETICS, INCORPORATED interest and other income for the quarter ending 2013-03-31 was $28.00K, a 86.67% increase year-over-year.
- CYTOKINETICS, INCORPORATED interest and other income for fiscal 2015 was $156.00K, a 44.44% increase from fiscal 2014.
- CYTOKINETICS, INCORPORATED interest and other income for fiscal 2014 was $108.00K, a 38.98% decline from fiscal 2013.
- CYTOKINETICS, INCORPORATED interest and other income for fiscal 2013 was $177.00K, a 98.88% increase from fiscal 2012.
- CYTOKINETICS, INCORPORATED interest and other income for fiscal 2012 was $89.00K, a 37.76% decline from fiscal 2011.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month | Interest and Other Income 12 month | Interest and Other Income 12 month as first filed | Interest and Other Income 179 month | Interest and Other Income 182 month | Interest and Other Income 185 month | Interest and Other Income 188 month | Interest and Other Income 191 month | Interest and Other Income 194 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | $156.00K 10-K · filed 2016-03-03 | ||||||||||
| 2014-12-31 | $108.00K 10-K · filed 2016-03-03 | ||||||||||
| 2013-12-31 | $101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $125.00K derived: sum of 2 quarters · filed 2016-03-03 | $148.00K derived: sum of 3 quarters · filed 2016-03-03 | $177.00K 10-K · filed 2016-03-03 | $98.00K 10-K · filed 2014-03-07 | ||||||
| 2013-09-30 | $24.00K 10-Q · filed 2013-11-06 | $47.00K derived: sum of 2 quarters · filed 2013-11-06 | $76.00K 10-Q · filed 2013-11-06 | $108.00K derived: sum of 4 quarters · filed 2015-03-06 | $29.18M 10-Q · filed 2013-11-06 | ||||||
| 2013-06-30 | $23.00K 10-Q · filed 2013-08-07 | $52.00K 10-Q · filed 2013-08-07 | $84.00K derived: sum of 3 quarters · filed 2015-03-06 | $114.00K derived: sum of 4 quarters · filed 2015-03-06 | $29.15M 10-Q · filed 2013-08-07 | ||||||
| 2013-03-31 | $28.00K 10-Q · filed 2013-05-08 | $61.00K derived: sum of 2 quarters · filed 2015-03-06 | $91.00K derived: sum of 3 quarters · filed 2015-03-06 | $104.00K derived: sum of 4 quarters · filed 2015-03-06 | $29.13M 10-Q · filed 2013-05-08 | ||||||
| 2012-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-06 | $63.00K derived: sum of 2 quarters · filed 2015-03-06 | $76.00K derived: sum of 3 quarters · filed 2015-03-06 | $89.00K 10-K · filed 2015-03-06 | $29.10M 10-K · filed 2013-03-15 | ||||||
| 2012-09-30 | $30.00K 10-Q · filed 2013-11-06 | $43.00K derived: sum of 2 quarters · filed 2013-11-06 | $56.00K 10-Q · filed 2013-11-06 | $82.00K derived: sum of 4 quarters · filed 2014-03-07 | $29.07M 10-Q · filed 2012-11-07 | ||||||
| 2012-06-30 | $13.00K 10-Q · filed 2013-08-07 | $28.00K 10-Q · filed 2013-08-07 | $52.00K derived: sum of 3 quarters · filed 2014-03-07 | $88.00K derived: sum of 4 quarters · filed 2014-03-07 | $29.04M 10-Q · filed 2012-08-06 | ||||||
| 2012-03-31 | $15.00K 10-Q · filed 2013-05-08 | $39.00K derived: sum of 2 quarters · filed 2014-03-07 | $75.00K derived: sum of 3 quarters · filed 2014-03-07 | $104.00K derived: sum of 4 quarters · filed 2014-03-07 | |||||||
| 2011-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $60.00K derived: sum of 2 quarters · filed 2014-03-07 | $89.00K derived: sum of 3 quarters · filed 2014-03-07 | $143.00K 10-K · filed 2014-03-07 | |||||||
| 2011-09-30 | $36.00K 10-Q · filed 2012-11-07 | $65.00K derived: sum of 2 quarters · filed 2012-11-07 | $119.00K 10-Q · filed 2012-11-07 | ||||||||
| 2011-06-30 | $29.00K 10-Q · filed 2012-08-06 | $83.00K 10-Q · filed 2012-08-06 | |||||||||
| 2010-12-31 | $335.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |